South Africa

Saphra announces controlled compassionate access to ivermectin

Saphra announces controlled compassionate access to ivermectin

Saphra announces controlled compassionate access to ivermectin

By Kelly Jane Turner Time of article published 6m ago

Share this article:

ShareTweetShareShareShareEmailShare

Cape Town – The South African Health Products Regulatory Authority (Saphra) has announced that it will allow a controlled compassionate use of Ivermectin to treat Covid-19.

The health product regulator says it will unveil the access protocols for the drug in the coming days.

The announcement marks a shift in the position of Saphra who indicated that there must still be more comprehensive clinical trials done for full access to the drug to be allowed.

“We at Sahpra have considered all of this, and the approach that we will be taking going forward is that we will facilitate a controlled, compassionate, access program for Ivermectin. This does not mean that our position changes around the lack of availability of scientific data, but we had to as a regulator have very in-depth discussions around the context which we find ourselves in with the pandemic with limited options,” said saphra chief executive Dr Boitumelo Semete-Makokotlela.

*This is a developing story

Original Article

Related posts

WATCH: Woman uses black g-string to cover her mouth and nose while paying for shopping

News

WATCH: Mask-less woman uses black thong to cover her mouth and nose while paying for shopping

News

Ashley Judd sends shout-out to ’top notch’ SA hospital staff as she continues treatment in US

News